Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8673)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 28, 2021 (publication date) through Feb 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vasques-Monteiro IML, Souza-Mello V. Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight. World J Gastroenterol 2021; 27(16): 1738-1750 [PMID: 33967554 DOI: 10.3748/wjg.v27.i16.1738] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i16/1738.htm |
| Number | Citing Articles |
| 1 |
Luca Miele, Cecilia Napodano, Alfredo Cesario, Antonio De Magistris, Krizia Pocino, Umberto Basile, Gian L. Rapaccini, Antonio Gasbarrini, Antonio Grieco. COVID‐19, adaptative immune response and metabolic‐associated liver disease. Liver International 2021; 41(11): 2560 doi: 10.1111/liv.15061
|
| 2 |
Antonis S. Manolis, Antonis A. Manolis, Theodora A. Manolis, Naomi E. Apostolaki, Helen Melita. COVID-19 infection and body weight: A deleterious liaison in a J-curve relationship. Obesity Research & Clinical Practice 2021; 15(6): 523 doi: 10.1016/j.orcp.2021.10.006
|
| 3 |
Martín Uriel Vázquez‐Medina, Eira Cerda‐Reyes, Alberto Galeana‐Pavón, Carlos Enrique López‐Luna, Patty Marlen Ramírez‐Portillo, Gabriela Ibañez‐Cervantes, Julián Torres‐Vázquez, Cruz Vargas‐De‐León. Interaction of metabolic dysfunction‐associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019. Hepatology Communications 2022; 6(8): 2000 doi: 10.1002/hep4.1957
|
| 4 |
Mykhailo Buchynskyi, Iryna Kamyshna, Valentyn Oksenych, Nataliia Zavidniuk, Aleksandr Kamyshnyi. The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence. Viruses 2023; 15(5): 1072 doi: 10.3390/v15051072
|
| 5 |
Takako Nomura, Masafumi Ono, Kiyoyuki Kobayashi, Yuzuru Akaiwa, Maki Ayaki, Tomohiro Ogi, Maki Ogi, Hirokazu Takahashi, Kayo Ishikawa, Asahiro Morishita, Hideki Kobara, Tsutomu Masaki. Validation of fatty liver index as a predictor of hepatic steatosis in Asian populations: Impact of alcohol consumption and sex. Hepatology Research 2023; 53(10): 968 doi: 10.1111/hepr.13935
|
| 6 |
Carlos J. Pirola, Silvia Sookoian. COVID‐19 and non‐alcoholic fatty liver disease: Biological insights from multi‐omics data. Liver International 2023; 43(3): 580 doi: 10.1111/liv.15509
|
| 7 |
Zhao-Chun Chi. Progress in understanding of association between metabolic associated fatty liver disease and viral infectious diseases. World Chinese Journal of Digestology 2022; 30(18): 783 doi: 10.11569/wcjd.v30.i18.783
|
| 8 |
Raja Chakraborty, Deepak Sharma, Devesh U Kapoor, Akanksha Dwivedi, Rakhi Khabiya, Saikat Sen. Implications of metabolic dysfunction associated fatty liver disease in COVID-19. World Journal of Clinical Cases 2023; 11(6): 1275-1286 doi: 10.12998/wjcc.v11.i6.1275
|